跳到主要导航 跳到搜索 跳到主要内容

Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)

  • Juan Li
  • , Jie Liu
  • , Zheyong Liang
  • , Fang He
  • , Lu Yang
  • , Pingping Li
  • , Yina Jiang
  • , Bo Wang
  • , Can Zhou
  • , Yaochun Wang
  • , Yu Ren
  • , Jin Yang
  • , Jianmin Zhang
  • , Zhijun Luo
  • , Cyrus Vaziri
  • , Peijun Liu
  • The First Affiliated Hospital of Xi’an Jiaotong University
  • Roswell Park Cancer Institute
  • Boston University
  • University of North Carolina at Chapel Hill

科研成果: 期刊稿件评论/辩论

摘要

Retraction Note to: Cell Death and Diseasehttps://doi.org/10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.

源语言英语
文章编号860
期刊Cell Death and Disease
16
1
DOI
出版状态已出版 - 12月 2025
已对外发布

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Retraction note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth (Cell Death & Disease, (2017), 8, 3, (e2673), 10.1038/cddis.2017.46)' 的科研主题。它们共同构成独一无二的指纹。

引用此